Cancer dormancy: Isolation and characterization of dormant lymphoma cells

Eitan Yefenof; Louis J. Picker; Richard H. Scheuermann; Thomas F. Tucker; Ellen S. Vitetta; Jonathan W. Uhr

doi:10.1073/pnas.90.5.1829

Cancer dormancy: Isolation and characterization of dormant lymphoma cells

Eitan Yefenof, Louis J. Picker, Richard H. Scheuermann, Thomas F. Tucker, Ellen S. Vitetta, Jonathan W. Uhr

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Abstract

"Tumor dormancy" is an operational term used to describe a prolonged quiescent state in which tumor cells are present, but tumor progression is not clinically apparent. Although clinical examples of tumor dormancy abound, little is known regarding the mechanisms underlying this state. Here we utilize an antibody-induced dormancy model of an aggressive murine B-cell lymphoma (BCL₁) and show that the induction of the dormant state is accompanied by dramatic changes in tumor cell morphology and cell cycle status. These data indicate the feasibility of altering the malignant phenotype of transformed cells by specific signals originating at the cell surface, and they suggest new opportunities for therapeutic intervention in cancer.

Original language	English (US)
Pages (from-to)	1829-1833
Number of pages	5
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	90
Issue number	5
DOIs	https://doi.org/10.1073/pnas.90.5.1829
State	Published - Mar 1 1993
Externally published	Yes

ASJC Scopus subject areas

General

Access to Document

10.1073/pnas.90.5.1829

Cite this

@article{fe11924da0d84d378000dbc93a5ed2d7,

title = "Cancer dormancy: Isolation and characterization of dormant lymphoma cells",

abstract = "{"}Tumor dormancy{"} is an operational term used to describe a prolonged quiescent state in which tumor cells are present, but tumor progression is not clinically apparent. Although clinical examples of tumor dormancy abound, little is known regarding the mechanisms underlying this state. Here we utilize an antibody-induced dormancy model of an aggressive murine B-cell lymphoma (BCL1) and show that the induction of the dormant state is accompanied by dramatic changes in tumor cell morphology and cell cycle status. These data indicate the feasibility of altering the malignant phenotype of transformed cells by specific signals originating at the cell surface, and they suggest new opportunities for therapeutic intervention in cancer.",

author = "Eitan Yefenof and Picker, {Louis J.} and Scheuermann, {Richard H.} and Tucker, {Thomas F.} and Vitetta, {Ellen S.} and Uhr, {Jonathan W.}",

year = "1993",

month = mar,

day = "1",

doi = "10.1073/pnas.90.5.1829",

language = "English (US)",

volume = "90",

pages = "1829--1833",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "5",

}

TY - JOUR

T1 - Cancer dormancy

T2 - Isolation and characterization of dormant lymphoma cells

AU - Yefenof, Eitan

AU - Picker, Louis J.

AU - Scheuermann, Richard H.

AU - Tucker, Thomas F.

AU - Vitetta, Ellen S.

AU - Uhr, Jonathan W.

PY - 1993/3/1

Y1 - 1993/3/1

N2 - "Tumor dormancy" is an operational term used to describe a prolonged quiescent state in which tumor cells are present, but tumor progression is not clinically apparent. Although clinical examples of tumor dormancy abound, little is known regarding the mechanisms underlying this state. Here we utilize an antibody-induced dormancy model of an aggressive murine B-cell lymphoma (BCL1) and show that the induction of the dormant state is accompanied by dramatic changes in tumor cell morphology and cell cycle status. These data indicate the feasibility of altering the malignant phenotype of transformed cells by specific signals originating at the cell surface, and they suggest new opportunities for therapeutic intervention in cancer.

AB - "Tumor dormancy" is an operational term used to describe a prolonged quiescent state in which tumor cells are present, but tumor progression is not clinically apparent. Although clinical examples of tumor dormancy abound, little is known regarding the mechanisms underlying this state. Here we utilize an antibody-induced dormancy model of an aggressive murine B-cell lymphoma (BCL1) and show that the induction of the dormant state is accompanied by dramatic changes in tumor cell morphology and cell cycle status. These data indicate the feasibility of altering the malignant phenotype of transformed cells by specific signals originating at the cell surface, and they suggest new opportunities for therapeutic intervention in cancer.

UR - http://www.scopus.com/inward/record.url?scp=0027462883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027462883&partnerID=8YFLogxK

U2 - 10.1073/pnas.90.5.1829

DO - 10.1073/pnas.90.5.1829

M3 - Article

C2 - 8446596

AN - SCOPUS:0027462883

SN - 0027-8424

VL - 90

SP - 1829

EP - 1833

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 5

ER -

Cancer dormancy: Isolation and characterization of dormant lymphoma cells

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this